Management of Investigational Medicinal Products 
Clinical Trial Logistics
You are here : AccueilServices > Pharmaceutical Company Activity > Secondary packaging, labelling, release of IMP

Pharmaceutical Company Activity

Secondary packaging, labelling, release of IMP

Secondary packaging, labelling of IMP
  • Buying, reception and management of packaging and other relevant material
  • Reception of IMP semi-open
  • Creation of master label
  • Label printing
  • Redaction of master of secondary packaging
  • Packaging
  • Labelling
  • Quality control at each step of production
Relabelling IMP

During a study  and in the case of an extension of expiry dates, Theradis Pharma can organise the relabelling of the IMP.

Release of IMP
The certification, followed by release of IMP is carried out by the Qualified Person (Pharmacist), depending on the origin of the IMP, in accordance with the documentation assembled and conform with the European directive 2001/20 EC.